Zantac Cancer Risks Concealed By GlaxoSmithKline for Decades, Whistleblower Lawsuit Alleges
Glaxo first discovered a link between NDMA in Zantac and cancer at least four decades ago, according to the lawsuit filed by the independent testing lab that uncovered the cancer risks associated with the heartburn drug